Ogooluwa Ojelabi

527 total citations
13 papers, 402 citations indexed

About

Ogooluwa Ojelabi is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Virology. According to data from OpenAlex, Ogooluwa Ojelabi has authored 13 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 2 papers in Pathology and Forensic Medicine and 2 papers in Virology. Recurrent topics in Ogooluwa Ojelabi's work include Metabolism, Diabetes, and Cancer (5 papers), Amino Acid Enzymes and Metabolism (2 papers) and HIV Research and Treatment (2 papers). Ogooluwa Ojelabi is often cited by papers focused on Metabolism, Diabetes, and Cancer (5 papers), Amino Acid Enzymes and Metabolism (2 papers) and HIV Research and Treatment (2 papers). Ogooluwa Ojelabi collaborates with scholars based in United States, Canada and United Kingdom. Ogooluwa Ojelabi's co-authors include Anthony Carruthers, Julie K. De Zutter, A. Simon, Lynn McKeown, Suman R. Das, Karen E. Porter, Richard Foster, David J. Beech, Jing Li and Martin Stacey and has published in prestigious journals such as Journal of Biological Chemistry, Cell Metabolism and Journal of Virology.

In The Last Decade

Ogooluwa Ojelabi

13 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ogooluwa Ojelabi United States	10	232	75	42	41	35	13	402
Roseline Guibon France	12	198 0.9×	88 1.2×	44 1.0×	31 0.8×	42 1.2×	20	428
Juli Liu China	13	422 1.8×	215 2.9×	21 0.5×	38 0.9×	20 0.6×	23	636
Natsuko Kageyama‐Yahara Japan	14	218 0.9×	38 0.5×	28 0.7×	139 3.4×	30 0.9×	22	520
Suneetha Amara United States	12	167 0.7×	78 1.0×	11 0.3×	103 2.5×	86 2.5×	23	424
H Liu China	10	361 1.6×	28 0.4×	15 0.4×	47 1.1×	47 1.3×	21	495
Xiaowei Ma China	11	249 1.1×	41 0.5×	15 0.4×	39 1.0×	33 0.9×	24	606
Laishram Pradeepkumar Singh India	9	133 0.6×	50 0.7×	11 0.3×	84 2.0×	28 0.8×	10	375
Ankita Singh India	10	230 1.0×	51 0.7×	6 0.1×	55 1.3×	43 1.2×	13	369
Bin Wen China	14	296 1.3×	49 0.7×	7 0.2×	56 1.4×	50 1.4×	36	523
Shangyi Fu United States	14	367 1.6×	143 1.9×	21 0.5×	37 0.9×	78 2.2×	32	672

Countries citing papers authored by Ogooluwa Ojelabi

Since Specialization

Citations

This map shows the geographic impact of Ogooluwa Ojelabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ogooluwa Ojelabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ogooluwa Ojelabi more than expected).

Fields of papers citing papers by Ogooluwa Ojelabi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ogooluwa Ojelabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ogooluwa Ojelabi. The network helps show where Ogooluwa Ojelabi may publish in the future.

Co-authorship network of co-authors of Ogooluwa Ojelabi

This figure shows the co-authorship network connecting the top 25 collaborators of Ogooluwa Ojelabi. A scholar is included among the top collaborators of Ogooluwa Ojelabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ogooluwa Ojelabi. Ogooluwa Ojelabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Ramalho, Theresa, Patrícia A. Assis, Ogooluwa Ojelabi, et al.. (2024). Itaconate impairs immune control of Plasmodium by enhancing mtDNA-mediated PD-L1 expression in monocyte-derived dendritic cells. Cell Metabolism. 36(3). 484–497.e6. 32 indexed citations

Liu, Pengpeng, Ogooluwa Ojelabi, Xin D. Gao, et al.. (2022). Adenine Base Editing In Vivo with a Single Adeno-Associated Virus Vector. PubMed. 1(3). 285–299. 43 indexed citations

Ojelabi, Ogooluwa, et al.. (2021). Orthogonal CRISPR-Cas tools for genome editing, inhibition, and CRISPR recording in zebrafish embryos. Genetics. 220(1). 15 indexed citations

Obayemi, John D., et al.. (2020). LHRH-Conjugated Drugs as Targeted Therapeutic Agents for the Specific Targeting and Localized Treatment of Triple Negative Breast Cancer. Scientific Reports. 10(1). 8212–8212. 35 indexed citations

Adejumo, Adeyinka, Tokunbo Ajayi, Oluwole Adegbala, et al.. (2018). Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease. Liver International. 38(8). 1475–1486. 35 indexed citations

Ojelabi, Ogooluwa, et al.. (2018). Red wine and green tea flavonoids are cis-allosteric activators and competitive inhibitors of glucose transporter 1 (GLUT1)-mediated sugar uptake. Journal of Biological Chemistry. 293(51). 19823–19834. 28 indexed citations

Ojelabi, Ogooluwa, et al.. (2017). Reconciling contradictory findings: Glucose transporter 1 (GLUT1) functions as an oligomer of allosteric, alternating access transporters. Journal of Biological Chemistry. 292(51). 21035–21046. 20 indexed citations

Ojelabi, Ogooluwa, et al.. (2017). Kinetic Basis of Cis- and Trans-Allostery in GLUT1-Mediated Sugar Transport. The Journal of Membrane Biology. 251(1). 131–152. 3 indexed citations

Ojelabi, Ogooluwa. (2017). Small Molecule Modulation of GLUT1-Mediated Glucose Transport. University of Massachusetts (UMass) Chan Medical School. 3 indexed citations

10.

Ojelabi, Ogooluwa, et al.. (2016). WZB117 (2-Fluoro-6-(m-hydroxybenzoyloxy) Phenyl m-Hydroxybenzoate) Inhibits GLUT1-mediated Sugar Transport by Binding Reversibly at the Exofacial Sugar Binding Site. Journal of Biological Chemistry. 291(52). 26762–26772. 91 indexed citations

11.

Ojelabi, Ogooluwa, et al.. (2016). Novel small molecule, WZB117, competitively inhibit GLUT1‐mediated glucose transport to halt cancer growth. The FASEB Journal. 30(S1). 5 indexed citations

12.

Serquiña, Anna, et al.. (2013). UPF1 Is Crucial for the Infectivity of Human Immunodeficiency Virus Type 1 Progeny Virions. Journal of Virology. 87(16). 8853–8861. 40 indexed citations

13.

Li, Jing, Lynn McKeown, Ogooluwa Ojelabi, et al.. (2011). Nanomolar potency and selectivity of a Ca²⁺release-activated Ca²⁺channel inhibitor against store-operated Ca²⁺entry and migration of vascular smooth muscle cells. British Journal of Pharmacology. 164(2). 382–393. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact